Navigation Links
Lambda 10-2 Filter Wheel from AutoMate Scientific, Inc

ProductsLambda 10-2 Filter Wheel from AutoMate Scientific, Inc
Company AutoMate Scientific, Inc
Item Lambda 10-2 Filter Wheel
Price $5,150.00
Description The Lambda 10-2 is a microprocessor controlled, high speed filter wheel. Its impressive speed coupled with exceptionally smooth operation make the Lambda 10-2 ideal for research applications involving fluorescence microscopy, ratio imaging, spectrophotometry, visual physiology, or any application requiring rapid and accurate aperture positioning. The Lambda 10-2 controller which has both serial and parallel interfaces will drive up to two filter wheels and two shutters.
Info AutoMate Scientific, IncAutoMate Scientific, Inc
650 University Ave #5
Berkeley, CA 94710

Call AutoMate Scientific, Inc to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-510-725-4910
Customer Service: 510-845-6283
Fax Number: 510-665-3975
Web Site: http://www.autom8.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Lambda Protein Phosphatase from New England Biolabs
2. Lambda Protein Phosphatase from New England Biolabs
3. Lambda Control Kit from ABgene
4. Mouse Anti-Lambda Free Light Chain Monoclonal Antibody, Unconjugated, Clone 3D12 from GeneTex
5. MaxPlax Lambda Packaging Extract from EPICENTRE Biotechnologies
6. Lambda GT11 Reverse DNA Sequencing Primer from EPICENTRE Biotechnologies
7. Lambda GT11 Forward DNA Sequencing Primer from EPICENTRE Biotechnologies
8. Mouse Anti-Rat Kappa, Lambda Light Chain Monoclonal Antibody, Horseradish Peroxidase Conjugated from AbD Serotec
9. Lambda Control Template and Primer from Takara Mirus Bio
10. Anti-Human Ig Lambda-chain Monoclonal Antibody, Unconjugated, Clone ICO-16 from Cell Sciences
11. MicroBeta Filtermat-96 Harvester from PerkinElmer
(Date:9/16/2014)... Menopause Society (NAMS) has published its key, evidence-based ... everything from hot flashes to heart disease. The ... for Clinical Care of Midlife Women," was published ... . This is the first, comprehensive set of ... freely available to all clinicians who care for ...
(Date:9/16/2014)... Two Johns Hopkins neuroscientists have discovered the "molecular brakes" ... inner ear cochleas of mice. These "hair cells" translate ... the brain and are interpreted as sounds. If the ... , A summary of the research will be ... Sept. 16. , "The proteins Hey1 and Hey2 act ...
(Date:9/16/2014)... inherit certain traits from our parents that are pre-determined. ... play out by taking certain drugs or better yet, ... team of researchers at the Boston University School of ... research. , Epigenetics regulates gene expression in a ... which prevent permanent mutations or alterations within the gene ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3
... world,s top biodiversity hotspot for reptiles and amphibians, according ... from the University of California, Berkeley, Southern Illinois University ... The park, which encompasses lowland Amazonian rain forest, high-altitude ... well known for its huge variety of bird life, ...
... to climate change are being compiled by research groups ... various sources results in different climate projections; hence, the ... arrive at a consensus regarding future climate estimates. ... SIAM Journal on Uncertainty Quantification , authors Matthew ...
... , New Rochelle, NY, February 19, 2014Joseph C. Glorioso, ... devoted much of his research career to developing herpes ... cells. In recognition of his leadership and accomplishments, ... Gene Therapy , a peer-reviewed journal from Mary Ann ...
Cached Biology News:Peru's Manu National Park sets new biodiversity record 2Peru's Manu National Park sets new biodiversity record 3Statistics research could build consensus around climate predictions 2Statistics research could build consensus around climate predictions 3Statistics research could build consensus around climate predictions 4Joseph Glorioso, Ph.D., receives Pioneer Award 2
(Date:9/17/2014)... - Oncothyreon Inc. (NASDAQ: ONTY ) today ... of its Common Stock and Series A Convertible Preferred ... Series A Convertible Preferred Stock is non-voting and convertible ... will be prohibited if, as a result, the holder ... of the Common Stock then outstanding. As part of ...
(Date:9/17/2014)... 17, 2014 A biodegradable polymer ... such as bacteria, fungi, and algae into smaller ... biomass, inorganic compounds, carbon dioxide, and humus in ... base and improved costs, biodegradable polymers are proving ... alternative to conventional polymers. Primary factors that are ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced that it has been ... and Trademark Office on its unique delivery system ... ) to phagocytic cells for the treatment of ...
Breaking Biology Technology:Oncothyreon Announces Proposed Public Offerings 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4